1. Home
  2. SER vs BLAC Comparison

SER vs BLAC Comparison

Compare SER & BLAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • BLAC
  • Stock Information
  • Founded
  • SER 2017
  • BLAC 2020
  • Country
  • SER United States
  • BLAC United States
  • Employees
  • SER N/A
  • BLAC N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • BLAC
  • Sector
  • SER Health Care
  • BLAC
  • Exchange
  • SER Nasdaq
  • BLAC NYSE
  • Market Cap
  • SER 46.7M
  • BLAC 46.9M
  • IPO Year
  • SER 2018
  • BLAC 2023
  • Fundamental
  • Price
  • SER $6.13
  • BLAC $11.26
  • Analyst Decision
  • SER
  • BLAC
  • Analyst Count
  • SER 0
  • BLAC 0
  • Target Price
  • SER N/A
  • BLAC N/A
  • AVG Volume (30 Days)
  • SER 37.9K
  • BLAC 9.1K
  • Earning Date
  • SER 11-12-2024
  • BLAC 01-01-0001
  • Dividend Yield
  • SER N/A
  • BLAC N/A
  • EPS Growth
  • SER N/A
  • BLAC N/A
  • EPS
  • SER N/A
  • BLAC N/A
  • Revenue
  • SER $3,157,500.00
  • BLAC N/A
  • Revenue This Year
  • SER N/A
  • BLAC N/A
  • Revenue Next Year
  • SER N/A
  • BLAC N/A
  • P/E Ratio
  • SER N/A
  • BLAC N/A
  • Revenue Growth
  • SER 2454.55
  • BLAC N/A
  • 52 Week Low
  • SER $3.81
  • BLAC $10.45
  • 52 Week High
  • SER $23.18
  • BLAC $13.40
  • Technical
  • Relative Strength Index (RSI)
  • SER 58.82
  • BLAC 49.52
  • Support Level
  • SER $4.15
  • BLAC $11.05
  • Resistance Level
  • SER $6.24
  • BLAC $12.43
  • Average True Range (ATR)
  • SER 0.73
  • BLAC 0.24
  • MACD
  • SER 0.08
  • BLAC -0.01
  • Stochastic Oscillator
  • SER 84.62
  • BLAC 15.22

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

About BLAC BELLEVUE LIFE SCIENCES ACQ CORP

Bellevue Life Sciences Acquisition Corp is a blank check company.

Share on Social Networks: